FULL PRACTICE REDUCED PRACTICE NEW PATIENT NETWORKS Strengthen patient cover age, practice delive... more FULL PRACTICE REDUCED PRACTICE NEW PATIENT NETWORKS Strengthen patient cover age, practice delivery, & the healthcare system COVERAGE EXPANSION Access to care and coverage expansion to >34 million individuals ! DELIVERY SYSTEMS REFORM Innovative health care models emphasis on care coordination, EBP, & quality outcomes ! HEALTH INSURANCE EXCHANGES Consumer protections hold insurers accountable ! COST CONTAINMENT Reduction in administrative burden lending to more time with patients ! Health Reform: Five Key Benefits ! Patient-Centered Medical Home (PCMH) is an enhanced primary care model with improved expanded access to care, coordination of care, emphasis on health promotion/prevention, high-quality and safety.
Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million perso... more Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million persons in the U.S. affected (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2008). Racial and ethnic minorities, such as African Americans and Hispanics, have an increased risk as they are twice as likely as non-Hispanic whites of similar age to develop T2D. T2D is the primary cause of blindness, renal failure, and nontraumatic amputation in adults in the U.S. T2D also increases the risk of heart disease and stroke 2-to 4-fold (Centers for Disease Control & Prevention [CDC], 2008]). Complications often occur concomitantly and contribute to disability, personal suffering, and considerable societal costs. In the U.S., the economic costs of diabetes in 2007 were estimated to be $172 billion, an increase of 32% from 2002 American Diabetes Association (ADA, 2003,2008). Therefore, the greatest opportunity to address the individual and societal costs of T2D is through disease prevention. T2D is a heterogenous disease characterized by hyperglycemia due to dysfunction fo pancreatic islet-cells, increased hepatic glucose production, and insulin resistance (IR). T2D is preceded by a sustained period of impaired glucose tolerance (IGT) or less severe disturbances in glucose metabolism (Haffner, 2000). A diagnosis of IGT contributes to a high likelihood of developing T2D and a 1.5-fold risk of cardiovascular disease compared to those with normal blood glucose levels (Coutinho
Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million perso... more Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million persons in the U.S. affected (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2008). Racial and ethnic minorities, such as African Americans and Hispanics, have an increased risk as they are twice as likely as non-Hispanic whites of similar age to develop T2D. T2D is the primary cause of blindness, renal failure, and nontraumatic amputation in adults in the U.S. T2D also increases the risk of heart disease and stroke 2-to 4-fold (Centers for Disease Control & Prevention [CDC], 2008]). Complications often occur concomitantly and contribute to disability, personal suffering, and considerable societal costs. In the U.S., the economic costs of diabetes in 2007 were estimated to be $172 billion, an increase of 32% from 2002 American Diabetes Association (ADA, 2003,2008). Therefore, the greatest opportunity to address the individual and societal costs of T2D is through disease prevention. T2D is a heterogenous disease characterized by hyperglycemia due to dysfunction fo pancreatic islet-cells, increased hepatic glucose production, and insulin resistance (IR). T2D is preceded by a sustained period of impaired glucose tolerance (IGT) or less severe disturbances in glucose metabolism (Haffner, 2000). A diagnosis of IGT contributes to a high likelihood of developing T2D and a 1.5-fold risk of cardiovascular disease compared to those with normal blood glucose levels (Coutinho
FULL PRACTICE REDUCED PRACTICE NEW PATIENT NETWORKS Strengthen patient cover age, practice delive... more FULL PRACTICE REDUCED PRACTICE NEW PATIENT NETWORKS Strengthen patient cover age, practice delivery, & the healthcare system COVERAGE EXPANSION Access to care and coverage expansion to >34 million individuals ! DELIVERY SYSTEMS REFORM Innovative health care models emphasis on care coordination, EBP, & quality outcomes ! HEALTH INSURANCE EXCHANGES Consumer protections hold insurers accountable ! COST CONTAINMENT Reduction in administrative burden lending to more time with patients ! Health Reform: Five Key Benefits ! Patient-Centered Medical Home (PCMH) is an enhanced primary care model with improved expanded access to care, coordination of care, emphasis on health promotion/prevention, high-quality and safety.
Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million perso... more Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million persons in the U.S. affected (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2008). Racial and ethnic minorities, such as African Americans and Hispanics, have an increased risk as they are twice as likely as non-Hispanic whites of similar age to develop T2D. T2D is the primary cause of blindness, renal failure, and nontraumatic amputation in adults in the U.S. T2D also increases the risk of heart disease and stroke 2-to 4-fold (Centers for Disease Control & Prevention [CDC], 2008]). Complications often occur concomitantly and contribute to disability, personal suffering, and considerable societal costs. In the U.S., the economic costs of diabetes in 2007 were estimated to be $172 billion, an increase of 32% from 2002 American Diabetes Association (ADA, 2003,2008). Therefore, the greatest opportunity to address the individual and societal costs of T2D is through disease prevention. T2D is a heterogenous disease characterized by hyperglycemia due to dysfunction fo pancreatic islet-cells, increased hepatic glucose production, and insulin resistance (IR). T2D is preceded by a sustained period of impaired glucose tolerance (IGT) or less severe disturbances in glucose metabolism (Haffner, 2000). A diagnosis of IGT contributes to a high likelihood of developing T2D and a 1.5-fold risk of cardiovascular disease compared to those with normal blood glucose levels (Coutinho
Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million perso... more Type 2 diabetes (T2D) is emerging as a public health epidemic with approximately 24 million persons in the U.S. affected (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2008). Racial and ethnic minorities, such as African Americans and Hispanics, have an increased risk as they are twice as likely as non-Hispanic whites of similar age to develop T2D. T2D is the primary cause of blindness, renal failure, and nontraumatic amputation in adults in the U.S. T2D also increases the risk of heart disease and stroke 2-to 4-fold (Centers for Disease Control & Prevention [CDC], 2008]). Complications often occur concomitantly and contribute to disability, personal suffering, and considerable societal costs. In the U.S., the economic costs of diabetes in 2007 were estimated to be $172 billion, an increase of 32% from 2002 American Diabetes Association (ADA, 2003,2008). Therefore, the greatest opportunity to address the individual and societal costs of T2D is through disease prevention. T2D is a heterogenous disease characterized by hyperglycemia due to dysfunction fo pancreatic islet-cells, increased hepatic glucose production, and insulin resistance (IR). T2D is preceded by a sustained period of impaired glucose tolerance (IGT) or less severe disturbances in glucose metabolism (Haffner, 2000). A diagnosis of IGT contributes to a high likelihood of developing T2D and a 1.5-fold risk of cardiovascular disease compared to those with normal blood glucose levels (Coutinho
Uploads
Papers by Stacie Zibel